Company name |
Beschreibung |
|---|---|
| Metabometrix |
Metabonomics characterises the key biochemical changes caused by a range of interventions and conditions, such as drug toxicity in animals and man, the diagnosis and course of clinical disease, the effects of therapeutic intervention and the impact of nutrition and life-style changes |
| METabolic EXplorer |
Fermentation-based industrial processes |
| Mendel Biotechnology, Inc. |
Plant Gene Regulatory Networks |
| Media Cybernetics |
Software provider, who develops digital image processing solutions to extract knowledge from and manage image databases. |
| McKesson Corp. |
EMR Software |
| MCGC - Mediconsult Group of Companies |
Mediconsult Group of Companies includes several individual companies, providing services in support of the pharmaceutical industry such as clinical research, drug registration, medical writing, translations, validation, and logistics and training |
| Maybridge |
Facilitating the search for bioactive molecules |
| Maxygen |
Protein pharmaceuticals for the treatment of chemotherapy-induced neutropenia (CIN) and acute radiation syndrome (ARS). |
| Matrox |
Software and hardware solutions for graphics, video, and imaging/machine vision applications |
| Matrix Science |
Identification, characterisation and quantitation of proteins using mass spectrometry data |
| MathWorks |
Technical computing software for engineers and scientists in industry, government, and education. |
| Macrogen |
Medicine development capabilities based on race-specific "medical treatment/gene information integrated content" |
| LYNK Biotechnology |
Healthcare and cosmetic products and services |
| Lundbeck |
Central nervous system (CNS) disorders |
| Luminex Corporation |
Biological testing technologies |
| Ludesi |
Software and services for 2D gel image analysis |
| Lorus Therapeutics |
Cancer drug development |
| Long Island Scientific |
Liquid Scintillation Counters, Gamma Counters, Centrifuges, Spectrophotometers and Microplate Instrumentation |
| LINCO Research Inc. |
Serologicals Corporation (NASDAQ: SERO) announced that it has completed its acquisition of LINCO. Millipore Corporation (MIL) completes acquisition of Serologicals Corporation (SERO) in 22006. |
| Ligand |
Drug discovery and development |